Nicole Prosperie, MD
Obstetrics & Gynecology · Thibodaux, LANPI 1225229552
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $638 and has fallen 57.8% since, to $269 in 2025.
Across 150 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$539
- Exeltis, USA Inc.$310
- Sumitomo Pharma America, Inc.$224
- Amgen$212
- Mayne Pharma Commercial LLC$172
- Pfizer$166
- plus $924 from 23 others
What the payments were for
- Food & beverage$2,548100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $539 |
| Exeltis, USA Inc. | 14 | $310 |
| Sumitomo Pharma America, Inc. | 17 | $224 |
| Amgen | 13 | $212 |
| Mayne Pharma Commercial LLC | 11 | $172 |
| Pfizer | 10 | $166 |
| Astellas Pharma US Inc | 7 | $126 |
| Avion Pharmaceuticals | 7 | $111 |
| Organon | 4 | $64 |
| Bayer | 4 | $57 |
| Hologic Sales And Service, LLC | 2 | $56 |
| Mylan Pharmaceuticals Inc. | 3 | $56 |
| Smith+Nephew | 2 | $48 |
| Myovant Sciences Inc. | 3 | $45 |
| Radius Health, Inc. | 3 | $44 |
| Aspira Women's Health Inc | 1 | $42 |
| Vertical Pharmaceuticals, LLC | 3 | $41 |
| Agile Therapeutics, Inc. | 3 | $37 |
| Millicent US Inc | 2 | $30 |
| Convatec Inc. | 1 | $28 |
| Duchesnay USA Incorporated | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Evofem Biosciences, Inc. | 4 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Merck | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Virtus Pharmaceuticals LLC | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
| Ferring Pharmaceuticals Inc. | 1 | $11 |
How this compares
$2,548 in reported general payments places this provider in the 70th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 37 | $1,909 |
| Raloxifene Hcl | 15 | $560 |
| ValacyclovirValacyclovir Hcl | 13 | $515 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $220 |
| Zolpidem Tartrate | 17 | $200 |
| Alendronate Sodium | 31 | $198 |
| Clobetasol Propionate | 11 | $186 |
| Paroxetine Hcl | 11 | $49 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Thibodaux
- Johnathan WiseThibodaux$7K
- Veronica GillispieNew Orleans$117K
- Rachel Bezdekla Place$105K
- Earl PeeperNew Orleans$95K
- Thomas PayneBaton Rouge$84K
- Catherine VanderloosShreveport$55K
- George MorrisNew Orleans$34K
- Russell PhelpsLafayette$31K
- Rachelle MeauxLafayette$31K
- Leonard BlantonBossier City$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.